Flythe, Jennifer E.
Karlsson, Niklas
Sundgren, Anna
Cordero, Paul
Grandinetti, Amanda
Cremisi, Henry
Rydén, Anna
Article History
Received: 4 March 2021
Accepted: 4 June 2021
First Online: 23 June 2021
Declarations
:
: Not applicable.
: Not applicable.
: In the last 2 years, JEF has received speaking honoraria from the American Society of Nephrology and multiple universities as well as investigator-initiated research funding from the Renal Research Institute, a subsidiary of Fresenius Kidney Care, North America. J.E.F. is on the medical advisory board to NxStage Medical, now owned by Fresenius Kidney Care, North America, and has received consulting fees from Fresenius Kidney Care, North America and AstraZeneca. NK, AS, HC, and AR are employees of AstraZeneca and hold shares in AstraZeneca. At the time of the study, PC was an employee of IQVIA, which received funds from AstraZeneca to conduct the review. AG is an employee of Goldfinch Bio, is the Vice Chair of the Kidney Health Initiative Patient and Family Partnership Council, and is the Vice Captain of Region 3 at the National Kidney Foundation.